Sanjeev Kumar

IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis

Rasmus Siersbæk, Valentina Scabia, Sankari Nagarajan et al. · Cancer Cell · 2020 · 258 citations · Full text

Medicine, Cancer Biology, Oncology +14

ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response

Sankari Nagarajan, Shalini V. Rao, Joseph E. Sutton et al. · Nature Genetics · 2020 · 181 citations · Full text

Medicine, Cancer Biology, Oncology +12

Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1–Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms

Peter W. Szlosarek, Melissa Phillips, Iuliia Pavlyk et al. · JTO Clinical and Research Reports · 2020 · 30 citations · Full text

Medicine, Oncology, Pharmacology +16

POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients

Richard D. Baird, Annelot G.J. van Rossum, Mafalda Oliveira et al. · Clinical Cancer Research · 2019 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

Patient satisfaction with telehealth consultations in medical oncology clinics: A cross-sectional study at a metropolitan centre during the COVID-19 pandemic.

Andrew Parsonson, Peter Grimison, Michael Boyer et al. · PubMed · 2024 · 19 citations

Pharmacy, Oncology, Health Communication +16